Quick Answer
IMMUCELL CORP /DE/ reported Common Stock Shares Outstanding of 9.05 million shares for the year ending 2025.
- IMMUCELL CORP /DE/ showed an increase of +0.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), IMMUCELL CORP /DE/'s Common Stock Shares Outstanding has grown by 196.1%.
- Historical annual values: Fiscal year 2025: 9.05 million shares | Fiscal year 2024: 8.98 million shares | Fiscal year 2023: 7.75 million shares | Fiscal year 2022: 7.75 million shares | Fiscal year 2021: 7.74 million shares | Fiscal year 2020: 7.22 million shares | Fiscal year 2019: 7.21 million shares | Fiscal year 2018: 5.57 million shares | Fiscal year 2017: 5.48 million shares | Fiscal year 2016: 4.85 million shares | Fiscal year 2015: 3.06 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: